Míriam Hernangómez

1.3k total citations
18 papers, 1.1k citations indexed

About

Míriam Hernangómez is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Míriam Hernangómez has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Míriam Hernangómez's work include Cannabis and Cannabinoid Research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Míriam Hernangómez is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Míriam Hernangómez collaborates with scholars based in Spain, France and Argentina. Míriam Hernangómez's co-authors include Carmen Guaza, Fernando Correa, Fabián Docagne, Leyre Mestre, Frida Loría, Vincenzo Di Marzo, Alessandra Spagnolo, José I. Borrell, Diego Clemente and Stefania Petrosino and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Experimental Medicine and Endocrinology.

In The Last Decade

Míriam Hernangómez

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Míriam Hernangómez Spain 16 592 306 294 193 157 18 1.1k
Irene Sánchez-Vera Spain 9 304 0.5× 296 1.0× 294 1.0× 210 1.1× 73 0.5× 9 914
Ana Rubio‐Araiz Spain 14 249 0.4× 239 0.8× 418 1.4× 252 1.3× 192 1.2× 14 1.0k
Ana I. Castillo Spain 17 616 1.0× 357 1.2× 105 0.4× 380 2.0× 77 0.5× 21 1.3k
Anders Ericsson‐Dahlstrand Sweden 13 198 0.3× 164 0.5× 279 0.9× 206 1.1× 292 1.9× 17 1.0k
Jameel Dennis United States 14 295 0.5× 212 0.7× 121 0.4× 455 2.4× 110 0.7× 16 1.0k
Rita Valenzuela Spain 25 343 0.6× 494 1.6× 253 0.9× 606 3.1× 61 0.4× 34 1.6k
María Pascual‐Lucas Spain 8 159 0.3× 156 0.5× 355 1.2× 363 1.9× 89 0.6× 14 972
Timothy M. Piser United States 15 537 0.9× 719 2.3× 94 0.3× 478 2.5× 28 0.2× 18 1.3k
Takako Takemiya Japan 15 215 0.4× 332 1.1× 176 0.6× 381 2.0× 92 0.6× 28 971
Daniele Lana Italy 19 141 0.2× 311 1.0× 485 1.6× 288 1.5× 94 0.6× 35 1.1k

Countries citing papers authored by Míriam Hernangómez

Since Specialization
Citations

This map shows the geographic impact of Míriam Hernangómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Míriam Hernangómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Míriam Hernangómez more than expected).

Fields of papers citing papers by Míriam Hernangómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Míriam Hernangómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Míriam Hernangómez. The network helps show where Míriam Hernangómez may publish in the future.

Co-authorship network of co-authors of Míriam Hernangómez

This figure shows the co-authorship network connecting the top 25 collaborators of Míriam Hernangómez. A scholar is included among the top collaborators of Míriam Hernangómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Míriam Hernangómez. Míriam Hernangómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abdulkarim, Baroj, Míriam Hernangómez, Mariana Igoillo‐Esteve, et al.. (2017). Guanabenz Sensitizes Pancreatic β Cells to Lipotoxic Endoplasmic Reticulum Stress and Apoptosis. Endocrinology. 158(6). 1659–1670. 19 indexed citations
3.
Rey, Adriana del, Carola W. Meyer, Míriam Hernangómez, et al.. (2015). Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine/paracrine manner. Molecular Psychiatry. 21(9). 1309–1320. 21 indexed citations
4.
Hernangómez, Míriam, Francisco J. Carrillo‐Salinas, Míriam Mecha, et al.. (2014). Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System. Current Pharmaceutical Design. 20(29). 4707–4722. 62 indexed citations
5.
Correa, Fernando, Míriam Hernangómez, & Carmen Guaza. (2013). Understanding Microglia–Neuron Cross Talk: Relevance of the Microglia–Neuron Cocultures. Methods in molecular biology. 1041. 215–229. 15 indexed citations
6.
Martín‐Fontecha, Mar, Óscar Palomares, Leyre Mestre, et al.. (2012). Chemical Probes for the Recognition of Cannabinoid Receptors in Native Systems. Angewandte Chemie International Edition. 51(28). 6896–6899. 34 indexed citations
7.
Hernangómez, Míriam, Leyre Mestre, Fernando Correa, et al.. (2012). CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia. 60(9). 1437–1450. 106 indexed citations
8.
Maris, Michael, Sofie Robert, Etienne Waelkens, et al.. (2012). Role of the Saturated Nonesterified Fatty Acid Palmitate in Beta Cell Dysfunction. Journal of Proteome Research. 12(1). 347–362. 41 indexed citations
9.
Martín‐Fontecha, Mar, Óscar Palomares, Leyre Mestre, et al.. (2012). Chemical Probes for the Recognition of Cannabinoid Receptors in Native Systems. Angewandte Chemie. 124(28). 7002–7005. 4 indexed citations
10.
Correa, Fernando, Maxime Gauberti, Jérôme Parcq, et al.. (2011). Tissue plasminogen activator prevents white matter damage following stroke. The Journal of Experimental Medicine. 208(6). 1229–1242. 72 indexed citations
11.
Loría, Frida, Stefania Petrosino, Míriam Hernangómez, et al.. (2009). An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiology of Disease. 37(1). 166–176. 67 indexed citations
12.
Correa, Fernando, Míriam Hernangómez, Leyre Mestre, et al.. (2009). Anandamide enhances IL‐10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF‐κB. Glia. 58(2). 135–147. 144 indexed citations
13.
Docagne, Fabián, Leyre Mestre, Frida Loría, et al.. (2008). Therapeutic potential of CB2 targeting in multiple sclerosis. Expert Opinion on Therapeutic Targets. 12(2). 185–195. 37 indexed citations
14.
Correa, Fernando, Fabián Docagne, Leyre Mestre, et al.. (2008). A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochemical Pharmacology. 77(1). 86–100. 81 indexed citations
15.
Loría, Frida, Stefania Petrosino, Leyre Mestre, et al.. (2008). Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide. European Journal of Neuroscience. 28(4). 633–641. 97 indexed citations
16.
Mestre, Leyre, Fabián Docagne, Fernando Correa, et al.. (2008). A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Molecular and Cellular Neuroscience. 40(2). 258–266. 98 indexed citations
17.
Docagne, Fabián, Diego Clemente, Carine Ali, et al.. (2007). Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Molecular and Cellular Neuroscience. 34(4). 551–561. 90 indexed citations
18.
Correa, Fernando, Fabián Docagne, Leyre Mestre, et al.. (2007). Cannabinoid System and Neuroinflammation: Implications for Multiple Sclerosis. NeuroImmunoModulation. 14(3-4). 182–187. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026